The present invention relates to a novel recombinant nanocage and use thereof. More particularly, the present invention relates to a nanocage formed by self-assembly of a fusion protein including a phagocytosis enhancing protein and a self-assembling protein, and a protein nanocage complex in which an immunogenic cell death inducer loaded in the nanocage as an active ingredient.